Diabetes - Epigenetics
21 – 30 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Pharmacoepigenetics in type 2 diabetes : is it clinically relevant?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Human Islet MicroRNA-200c Is Elevated in Type 2 Diabetes and Targets the Transcription Factor ETV5 to Reduce Insulin Secretion
(
- Contribution to journal › Article
-
Mark
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
(
- Contribution to journal › Article
-
Mark
Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes
2022) EASD, European Association for the Study of Diabetes, 58th annual meeting, In Diabetologia 65(Suppl 1).(
- Contribution to journal › Published meeting abstract
-
Mark
Adipose methylome integrative-omic analyses reveal genetic and dietary metabolic health drivers and insulin resistance classifiers
(
- Contribution to journal › Article
-
Mark
Epigenetic epidemiology and alterations in type 2 diabetes and obesity
2022) p.445-474(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Glucocorticoids and glucolipotoxicity alter the DNA methylome and function of human EndoC-βH1 cells
(
- Contribution to journal › Article
- 2021
-
Mark
Lifestyle Intervention in Pregnant Women With Obesity Impacts Cord Blood DNA Methylation, Which Associates With Body Composition in the Offspring
(
- Contribution to journal › Article
-
Mark
Excess of glucocorticoids during late gestation impairs the recovery of offspring’s β-cell function after a postnatal injury
(
- Contribution to journal › Article
-
Mark
Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids
(
- Contribution to journal › Article